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Idiopathic pulmonary hemosiderosis (IPH) is a rare unknown origin disease characterized by diffuse
alveolar hemorrhage (DPH). It rarely occurs in adults. We report a case of 50-year-old man, hospitalized
with acute respiratory insufﬁency. The chest radiograph and computed tomography scan showed
bilateral interstitial and ground-glass opacities. The diagnosis of IPH was conﬁrmed by broncho-alveolar
lavage (BAL) and surgical pulmonary biopsy. There was no sign of capillaritis or granuloma in the ana-
tomopathologic study. No remission was obtained after two months of high-dose corticosteroid therapy
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Idiopathic pulmonary hemosiderosis (IPH) is a rare disorder,
characterized by abnormal deposition of iron in the alveolar
macrophages as hemosiderin. It occurs commonly in children. In
adult, IPH is more frequent in men. Although, spontaneous
remissions are possible, the long term prognosis is poor. In fact,
most patients develop pulmonary ﬁbrosis within 5 years of
presentation.2. Case report
A 50-year-old man was admitted to our hospital because of
acute respiratory failure. The patient was a smoker (27 pack years)
and he had a past medical history of COPD since two years. Two
weeks before his hospitalization, the patient presented worsening
of the dyspnea. Physical examination showed cyanosis and bilateral
cracks. No other pathologic sign was found. Chest radiograph
showed reticulonodular opacities in the two lower lobes. Arterial
blood gas levels were as follows: pH 7.43, PO2 51 mmHg, PCO2
37 mmHg, HCO3 25 mmol/l. There was a moderate leukocytosiserosis; DPH, Diffuse alveolar
ronic obstructive pulmonary
ophil cytoplasmic antibodies;
nti nuclear antibodies; RF,
allah Fatma).
rved.(14,000 cells/mm3), anemia with a hemoglobin value of 10 g/dl and
the erythrocyte sedimentation level was 60 mm/h. The other
laboratory investigations, especially renal and liver functions were
normal and so was the coagulation proﬁle (PT 75%). Sputum stains
were negative for acid-fast bacteria. Computed tomography scan
showed diffuse nodules and patchy areas of ground-glass attenu-
ation, preferentially located in the lower lobes (Fig. 1). BAL was
done in the respiratory intensive care department and showed
a hemorrhagic ﬂuid with a large numbers of siderophages. The
Golde scorewas 12O conﬁrming the diagnosis of diffuse pulmonary
hemorrhage (DPH). The work-up for a speciﬁc etiology was nega-
tive. In fact, the patient had not received any treatment in the
preceding days and he had no abnormalities in physical examina-
tion of digestive, cardiovascular, neurological, renal and ORL
systems. No associated infection was identiﬁed. Coagulation
proﬁles, electrocardiogram and echocardiographywere normal and
so were the tests for hepatitis B and C. Laboratory investigations for
antineutrophil cytoplasmic antibodies (ANCA), anti-glomerular
basement membrane (GBM) antibodies, antiphospholipid anti-
bodies, anti nuclear antibodies (ANA) and rheumatoid factor (RF)
were negative. The patient underwent an open lung biopsy, the
histological study showed diffuse alveolar hemorrhage, the alveoli
were completely ﬁlled with hemosiderin-laden macophages with
positive Perls reaction. No sign of capillaritis, vasculitis, granuloma,
or malignancy was seen (Fig. 2). Hence the diagnosis of IPH was
conﬁrmed. Corticosteroid therapy was decided and the patient was
started on prednisone 1 mg/kg/day. One month later, the patient
had always dyspnea with severe hypoxemia in arterial blood gas
requiring continuous oxygen therapy. The chest roentgenogram
Fig. 1. Computed tomography scan of the chest showing bilateral ground-glass
opacities more pronounced in the lower lobes.
C.B. Abbdallah Fatma et al. / Respiratory Medicine CME 3 (2010) 238–240 239showed no improvement, with signs of ﬁbrosis. The patient died
two months after the onset of symptoms, because of progressive
respiratory failure.
3. Discussion
IPH is a rare disease; it occurs most frequently in children. An
incidence of 0.24 per million children per year has been esti-
mated in a Swedish study published in 1984.1 Its etiology is
unknown, but some hypotheses had been mentioned such as
immunological theory. In fact, IPH is occasionally associated with
celiac disease or immunoglobulin A gammapathy.2 The role of
inheritance and environmental factors has been discussed in
several reports.3,4Fig. 2. Lung biopsy specimen (HE 00). Alveoli engorged with hemosiderPatients with IPH have variable clinical presentation, they
usually have recurrent hemoptysis, cough and dyspnea.5,6 Although
in acute episode, hemoptysis may be absent and so it was in this
case.2 Respiratory failure has been described in acute phase.3 In
both, children and adults, radiographic ﬁndings are the same, they
consist in acute phase, of bilateral nodules and patchy areas of
ground-glass attenuation in high resolution computed tomog-
raphy.2 These ﬁndings are usually located in lower lobes. Lymph-
adenopathy and pleural effusions are not common.2 The BAL is very
helpful for diagnosis showing hemorrhagic ﬂuid with more than
20% of siderophages.3 Since our patient had not hemoptysis, the
diagnosis of DPH was made after the BAL.
The diagnosis of IPH is difﬁcult, it requires the exclusion of other
diseases which can be associated, such as cardiac diseases, bleeding
disorders, connective-tissue diseases (systemic lupus eryth-
ematosus and rheumatoid arthritis), systemic vasculitis (Wegner’s
granulomatosis or microscopic polyangiitis), or anti-basement-
membrane-antibody diseases (goodpasture’s syndrome).3,6 Labo-
ratory analysis for ANCA, anti GBM, antiphospholipid, ANA and RF
should so be negative.3,7 In our patient, they were all negative.
For deﬁnitive diagnosis, lung biopsy is necessary, the most
important features are, the presence of intact erythrocytes and
numerous siderophages in the alveoli and the absence of any other
pathologic sign: vascular malformation, immune deposition,
capillaritis, vasculitis, granuloma, malignancy.3
The efﬁcacy of corticosteroids in the treatment of IPH is difﬁcult
to assess, because of possible spontaneous remissions of the
disease and the lack of controlled studies on this subject.3 Adults
with IPH seem to respond more favorably to oral corticosteroid
therapy than children, in whom treatment can be problematic.
Other immunosuppressant drugs (azathioprine), especially in
combination with steroids may be effective in IPH exacerbations
with long survival, which may reach 20 years in small case series.8
A long term follow-up of IPH associated with celiac disease has also
been reported only with a gluten-free diet.9
The long term prognosis of the disease remains poor, and death
may be due to massive DPH or chronic respiratory failure becausein-laden macrophages. Cartouche: Positve Perls reaction (HE 200).
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disease; Even though, he was seen in an acute episode of DPH and
received high dose of prednisone, he rapidly developed pulmo-
nary ﬁbrosis. This may suggest an individual susceptibility for the
disease and encourage us to associate earlier corticosteroids and
immunosuppressant agents in these cases in order to improve
prognosis.
4. Conclusion
IPH in adults is a rare distinct entity with variable clinical
presentation. Its diagnosis is based on lung biopsy and exclusion of
other associated disorders. In order to improve its morbidity and
mortality, immunosuppressive agents should be associated rapidly
if there is no response to corticoids.
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